Hong Kong · Delayed Price · Currency is HKD Venus Medtech (Hangzhou) Statistics
Total Valuation
HKG:2500 has a market cap or net worth of HKD 523.29 million. The enterprise value is 674.98 million.
| Market Cap | 523.29M |
| Enterprise Value | 674.98M |
Important Dates
The next estimated earnings date is Tuesday, December 1, 2026.
| Earnings Date | Dec 1, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:2500 has 437.90 million shares outstanding.
| Current Share Class | 437.90M |
| Shares Outstanding | 437.90M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 16.66% |
| Owned by Institutions (%) | 6.13% |
| Float | 289.57M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 113.45 |
| PS Ratio | 1.78 |
| PB Ratio | 0.30 |
| P/TBV Ratio | 2.56 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.29 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.30, with a Debt / Equity ratio of 0.13.
| Current Ratio | 1.30 |
| Quick Ratio | 0.46 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.54 |
| Interest Coverage | -19.26 |
Financial Efficiency
Return on equity (ROE) is -25.85% and return on invested capital (ROIC) is -11.04%.
| Return on Equity (ROE) | -25.85% |
| Return on Assets (ROA) | -8.86% |
| Return on Invested Capital (ROIC) | -11.04% |
| Return on Capital Employed (ROCE) | -20.27% |
| Weighted Average Cost of Capital (WACC) | 9.70% |
| Revenue Per Employee | 528,833 |
| Profits Per Employee | -962,190 |
| Employee Count | 557 |
| Asset Turnover | 0.10 |
| Inventory Turnover | 0.89 |
Taxes
In the past 12 months, HKG:2500 has paid 3.77 million in taxes.
| Income Tax | 3.77M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -64.11% in the last 52 weeks. The beta is 1.16, so HKG:2500's price volatility has been higher than the market average.
| Beta (5Y) | 1.16 |
| 52-Week Price Change | -64.11% |
| 50-Day Moving Average | 1.11 |
| 200-Day Moving Average | 1.83 |
| Relative Strength Index (RSI) | 53.26 |
| Average Volume (20 Days) | 742,990 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:2500 had revenue of HKD 294.56 million and -535.94 million in losses. Loss per share was -1.22.
| Revenue | 294.56M |
| Gross Profit | 193.22M |
| Operating Income | -437.28M |
| Pretax Income | -532.17M |
| Net Income | -535.94M |
| EBITDA | -372.97M |
| EBIT | -437.28M |
| Loss Per Share | -1.22 |
Balance Sheet
The company has 82.30 million in cash and 234.00 million in debt, with a net cash position of -151.70 million or -0.35 per share.
| Cash & Cash Equivalents | 82.30M |
| Total Debt | 234.00M |
| Net Cash | -151.70M |
| Net Cash Per Share | -0.35 |
| Equity (Book Value) | 1.76B |
| Book Value Per Share | 4.02 |
| Working Capital | 124.22M |
Cash Flow
In the last 12 months, operating cash flow was -426.69 million and capital expenditures -5.59 million, giving a free cash flow of -432.28 million.
| Operating Cash Flow | -426.69M |
| Capital Expenditures | -5.59M |
| Depreciation & Amortization | 65.19M |
| Net Borrowing | -347.55M |
| Free Cash Flow | -432.28M |
| FCF Per Share | -0.99 |
Margins
Gross margin is 65.60%, with operating and profit margins of -148.45% and -181.95%.
| Gross Margin | 65.60% |
| Operating Margin | -148.45% |
| Pretax Margin | -180.67% |
| Profit Margin | -181.95% |
| EBITDA Margin | -126.62% |
| EBIT Margin | -148.45% |
| FCF Margin | n/a |
Dividends & Yields
HKG:2500 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -102.42% |
| FCF Yield | -82.61% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HKG:2500 has an Altman Z-Score of -2.14 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.14 |
| Piotroski F-Score | 1 |